State Treasurer State of Michigan Has $19.42 Million Position in Colgate-Palmolive (CL)

State Treasurer State of Michigan trimmed its position in Colgate-Palmolive (NYSE:CL) by 3.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 257,384 shares of the company’s stock after selling 9,900 shares during the period. State Treasurer State of Michigan’s holdings in Colgate-Palmolive were worth $19,420,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Jacobi Capital Management LLC boosted its position in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Krilogy Financial LLC boosted its position in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $122,000. AlphaMark Advisors LLC boosted its position in shares of Colgate-Palmolive by 1.5% during the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares in the last quarter. Finally, Bruderman Asset Management LLC purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $126,000. Hedge funds and other institutional investors own 73.10% of the company’s stock.

Colgate-Palmolive (NYSE:CL) opened at $69.76 on Friday. Colgate-Palmolive has a one year low of $66.26 and a one year high of $77.91. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42. The company has a market cap of $60,545.35, a PE ratio of 30.60, a PEG ratio of 2.55 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter in the prior year, the company posted $0.75 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. sell-side analysts forecast that Colgate-Palmolive will post 3.18 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s payout ratio is currently 70.18%.

In other news, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Noel R. Wallace sold 126,304 shares of the business’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the sale, the chief operating officer now owns 305,631 shares of the company’s stock, valued at approximately $22,549,455.18. The disclosure for this sale can be found here. Insiders have sold a total of 327,451 shares of company stock valued at $23,534,707 in the last quarter. Company insiders own 1.02% of the company’s stock.

Several equities research analysts have commented on the stock. Citigroup boosted their target price on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Jefferies Group reiterated a “hold” rating and issued a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, November 1st. Finally, KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $77.71.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.com-unik.info/2018/02/10/state-treasurer-state-of-michigan-has-19-42-million-position-in-colgate-palmolive-cl.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit